Page 125 - Interactive Theoritical Notes of Bioharmaceutics and pharamcokinetics.docx compressed
P. 125

PharmD clinical pharmacy program            Level 3, Semester 2          Biopharmaceutics & Pharmacokinetics (PT608(

                  1. Solutions

                    Drugs are generally absorbed more rapidly from solution.


                    The rate-limiting step is likely to be gastric emptying, particularly when the drug

                      is administered after meals.

                    However,  dilution  of  an  aqueous  solution  may  result  in  precipitation  in  the

                      following cases:

                  1.  Poorly  water-soluble  drug  whose  aqueous  solubility  had  been  increased  by

                      formulation techniques such as cosolvency, complex formation or solubilization

                      can result in precipitation of the drug in the gastric fluids.

                  2.  Exposure of an aqueous solution of a salt of a weak acidic compound to gastric

                      pH can also result in precipitation of the free acid form of the drug.

                    In most cases the extremely fine nature of the resulting precipitate permits a

                        more rapid rate of dissolution than if the drug had been administered in other

                        types of oral dosage forms, such as suspension, hard gelatin capsule or tablet.

                  2. Suspensions

                    A well-formulated suspension is second to a solution in efficiency of absorption.


                    Dissolution is the rate-limited factor in absorption of a drug from a suspension.

                    However,  drug  dissolution  from  a  suspension  can  be  rapid  if  very  fine  or

                      micronized  powders  are  used.  (These  have  a  larger  surface  area  or  specific

                      surface.)

                  3. Capsules

                       Unlike  the  tablets,  drug  particles  in  a  capsule  are  not  subjected  to  high

                         compression forces, which tend to compact the powder or granules and reduce

                         the effective surface area.

                       Hence, upon disruption of the shell, the encapsulated powder mass should

                         disperse rapidly to expose a large surface area to the GI fluid.



                                                                124
   120   121   122   123   124   125   126   127   128   129   130